Long-COVID Rate May Be Higher With Rheumatic Diseases
The results highlight the need for close monitoring and optimized multidisciplinary care for long-term adverse events after COVID-19 in patients with rheumatic disease.
Source: medscape.com
Stay updated with breaking news from Arvind Nune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The results highlight the need for close monitoring and optimized multidisciplinary care for long-term adverse events after COVID-19 in patients with rheumatic disease.
Despite the recent advancements in the treatment of polymyalgia rheumatica, a need for more research focused on finding non-steroidal treatment options remains.